Argus Research Downgrades Church & Dwight Co to Hold

Argus Research downgrades Church & Dwight Co (NYSE:CHD) from Buy to Hold.

Argus Research downgrades Church & Dwight Co (NYSE:CHD) from Buy to Hold.

Total
0
Shares
Related Posts
Read More

89bio To Present Additional Pegozafermin Data In Severe Hypertriglyceridemia From Phase 2 ENTRIGUE Study At American College Of Cardiology’s Annual Scientific Session Together With World Congress Of Cardiology

 89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today

ETNB